SCHEMBL24635258

SCHEMBL24635258

CNCC(C)[C@H](C)Nc1ccccc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.42
HTT P42858 1/20 0.42
TAAR1 Q96RJ0 1/20 0.39
P2RX7 Q99572 1/20 0.36
ADRB2 P07550 1/20 0.36
ADRB1 P08588 1/20 0.36
ADRB3 P13945 1/20 0.36
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
PGR P06401 1/20 0.36
SCN1A P35498 1/20 0.36
SCN2A Q99250 1/20 0.36
SCN3A Q9NY46 1/20 0.36
HPGD P15428 4/20 0.35
ALDH1A1 P00352 2/20 0.35
LMNA P02545 2/20 0.35
GAA P10253 2/20 0.35
KDM4E B2RXH2 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
ALOX12 P18054 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27360925 0.81 MAPT (0.45) MAPTHTTTAAR1P2RX7NPC1
SCHEMBL21675477 0.77 MAPT (0.46) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL30461968 0.76 MAPT (0.50) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL4750832 0.76 MAPT (0.50) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL245209 0.72 MAPT (0.50) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL9777532 0.71 MAPT (0.42) MAPTHTTP2RX7ADRB2ADRB1
SCHEMBL19399594 0.71 MAPT (0.45) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL17716129 0.71 MAPT (0.45) MAPTHTTP2RX7NPC1RAB9A
SCHEMBL11268371 0.70 MAPT (0.41) MAPTHTTP2RX7ADRB2ADRB1
SCHEMBL14930874 0.69 ALDH1A1 (0.50) MAPTHTTP2RX7NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022226408-A1 NOVEL ERGOLINES AND METHODS OF TREATING MOOD DISORDERS GILGAMESH PHARMACEUTICALS, INC. (US) 2022-10-27 WO disclosed